Vericel Corp

Insider buying surge at Vericel shows confidence in its tissue‑repair pipeline—executives pile on shares, hinting at a potential upside rebound despite recent slide.

Vericel insider trades reveal disciplined liquidity management and a long‑term bet on the company’s regenerative‑medicine pipeline, not a sign of panic.

Vericel insider trades reveal a disciplined buy‑sell‑exercise pattern, boosting confidence in the COO’s long‑term belief in the company’s regenerative‑medicine growth.